PharmacoEconomics

When Drugs Don't Work: Economic Assessment of Enhancing Compliance with Interventions Supported by Electronic Monitoring Devices
pp. 621-635(15)
Author: Hughes, Dyfrig

Impact of Pharmaceutical Prior Authorisation Policies: A Systematic Review of the Literature
pp. 637-648(12)
Authors: Puig-Junoy, Jaume; Moreno-Torres, Iván

The Contrast and Convergence of Bayesian and Frequentist Statistical Approaches in Pharmacoeconomic Analysis
pp. 649-664(16)
Author: Skrepnek, Grant H.

Healthcare Utilisation and Costs Associated with Adding Montelukast to Current Therapy in Patients with Mild to Moderate Asthma and Co-Morbid Allergic Rhinitis: PRAACTICAL Study
pp. 665-676(12)
Authors: Roberto Dal Negro,; Piskorz, Peter; Vives, Roberto; Guilera, Magda; Sazonov Kocevar, Vasilisa; Badia, Xavier

Direct Costs in Patients Hospitalised with Community-Acquired Pneumonia After Non-Response to Outpatient Treatment with Macrolide Antibacterials in the US
pp. 677-683(7)
Authors: Paladino, Joseph A.; Adelman, Martin H.; Schentag, Jerome J.; Iannini, Paul B.

A Stated Preference Binary Choice Experiment to Explore NICE Decision Making
pp. 685-693(9)
Authors: Tappenden, Paul; Brazier, John; Ratcliffe, Julie; Chilcott, James

A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease
pp. 695-711(17)
Authors: Mölken, Maureen P.M.H. Rutten-van; van Nooten, Floortje E.; Lindemann, Marion; Caeser, Manfred; Calverley, Peter M.A.